HIV Prevention Intervention for Young Transgender Women

Completed · Not applicable

Conditions studied: Sexual Transmission of Infection

In brief

The purpose of this study is to test the efficacy of a uniquely targeted HIV risk reduction intervention for young transgender women (YTW), ages 16 to 29, at risk for HIV acquisition or transmission.

Key facts

Study ID

NCT01575938

Run by

Ann & Robert H Lurie Children's Hospital of Chicago

People needed

300

Starts

2012-03-01

Expected to finish

2016-10-01

Last updated by the study team

2021-01-27

Who can join

Age: 16 and older, up to 29. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• age 16-29
• self-identified as transgender, transsexual, and/or female with a male biological or birth sex
• self-reported history of unprotected anal or vaginal intercourse, anal or vaginal sex with more than one sexual partner, anal or vaginal sex in exchange for money, food, shelter, or diagnosis with HIV or another STI in the previous 4 months
• able to speak and understand English
• willing and able to provide informed consent/assent
• intention to reside in the local area throughout the 12 month follow-up period

You may not qualify if…

• unable to provide informed consent due to severe mental or physical illness, or substance intoxication at the time of interview
• active suicidal ideation at the time of baseline interview

Where it is running

• Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States
• The Fenway Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.